Evolution of the Average Target: Exelon Corporation

Evolution of the Target Price: Exelon Corporation

Changes in Analyst Recommendations: Exelon Corporation

33252bb2a81.ymLHyw72oT0bVGODIrbT37SRxSxgEXAH0TBathN54IE.jlvqmkeGwwRXIhvISt617Nn48BhUJihvtAYym34Dhs6uLP-vPofbemI-Og~385b3962d3e41d2c0c078f47194a05ab
21/08 Morgan Stanley Adjusts Price Target on Exelon to $53 From $55, Keeps Equalweight Rating MT
19/08 JPMorgan Adjusts Exelon Price Target to $47 From $50 MT
31/07 BMO Capital Adjusts Price Target on Exelon to $47 From $48, Maintains Market Perform Rating MT
30/07 The Fed Gets a Better Inflation Number Zonebourse
29/07 Jefferies Adjusts Price Target on Exelon to $49 From $50, Maintains Hold Rating MT
22/07 Morgan Stanley Adjusts Price Target on Exelon to $55 From $54, Maintains Equalweight Rating MT
24/06 Morgan Stanley Adjusts Price Target on Exelon to $54 From $52, Maintains Equalweight Rating MT
21/05 Morgan Stanley Adjusts Price Target on Exelon to $52 From $55, Maintains Equalweight Rating MT
15/05 JPMorgan Adjusts Price Target on Exelon to $49 From $53, Maintains Neutral Rating MT
15/05 TD Cowen Adjusts Price Target on Exelon to $49 From $51, Maintains Hold Rating MT
13/05 KeyBanc Adjusts Price Target on Exelon to $41 From $43, Maintains Underweight Rating MT
11/05 Evercore ISI Adjusts Price Target on Exelon to $57 From $58 MT
28/04 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
22/04 BMO Capital Adjusts Exelon Price Target to $48 From $49, Maintains Market Perform Rating MT
21/04 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
21/04 KeyBanc Adjusts Price Target on Exelon to $43 From $44, Maintains Underweight Rating MT
20/04 Exelon Seen Offsetting PECO Rate Case Withdrawal Impact Over Time, RBC Says MT
20/04 Wells Fargo Adjusts Price Target on Exelon to $50 From $53, Maintains Overweight Rating MT
20/04 RBC Lowers Price Target on Exelon to $48 From $51, Keeps Sector Perform Rating MT
20/04 Jefferies Downgrades Exelon to Hold From Buy, Adjusts Price Target to $50 From $55 MT
18/04 Exelon Shares Fall After Multiple Downgrades MT
17/04 Mizuho Downgrades Exelon to Neutral From Outperform, Adjusts Price Target to $48 From $51 MT
17/04 Barclays Downgrades Exelon to Equalweight From Overweight, Adjusts PT to $49 From $50 MT
17/04 BMO Capital Downgrades Exelon to Market Perform From Outperform, Adjusts PT to $49 From $52 MT
17/04 Analyst recommendations: Albemarle, Newmont Corp, Texas Instruments, The Clorox Company, Oxy… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+10.32%
+33.42%
+16.82%
+1.9%
+7.26%
+11.47%
+25.1%
+12.9%
+17.29%
+7.3%
Average +14.38%
Weighted average by Cap. +16.67%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
44.31USD
Average target price
48.88USD
Spread / Average Target
+10.32%
High Price Target
58.00USD
Spread / Highest target
+30.90%
Low Price Target
41.00USD
Spread / Lowest Target
-7.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
JPMorgan Chase
BMO Capital
Jefferies & Co.
TD Cowen
KeyBanc Capital Markets
Evercore ISI
Wells Fargo Securities
RBC Capital Markets
Mizuho Securities
Barclays
Argus
UBS
Goldman Sachs
Scotiabank
Wolfe Research
BTIG
Guggenheim
BofA Securities
Seaport Global Securities
Credit Suisse
Vertical Research
Spin-Off Research
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
44.31USD
Average target price
48.88USD
Spread / Average Target
+10.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXC Stock
  4. Consensus Exelon Corporation